Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00935272 · ClinicalTrials.gov registry record · NA
Safety/Efficacy Study of Restylane® in Lip Augmentation
A NA study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT00935272: Completed NA study, sponsored by Medicis Global Service Corporation.
NCT00935272 is a NA study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00935272, a NA study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
To determine the safety and effectiveness of Restylane® when used for lip augmentation.
Primary Outcome
Assessment of lip fullness augmentation after treatment with Restylane, as compared to no treatment, at week 8 as compared to baseline assessment. Response was determined by at least one grade improvement from baseline in the upper and lower lips using the Medicis Lip Fullness Scale (MLFS). The MLFS is a 5 number scale with grading: (1) Very Thin, (2) Thin (3) Medium (4) Full and (5)Very Full.
Interventions
- DEVICE Restylane®
- DEVICE Non-Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2009-07 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT00935272 record still lists
NCT00935272 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 2 interventions - of which Restylane® is the first listed.
NCT00935272 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00935272 about?
NCT00935272 is a clinical study titled "Safety/Efficacy Study of Restylane® in Lip Augmentation". To determine the safety and effectiveness of Restylane® when used for lip augmentation.
What is the current status of trial NCT00935272?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2009-07. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00935272?
The interventions under investigation include: Restylane® (DEVICE), Non-Treatment (DEVICE).
Who is sponsoring clinical trial NCT00935272?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00935272's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia